Dual Roles for NFAT Transcription Factor Genes as Oncogenes and Tumor Suppressors

REFERENCES

• Akagi, K., T. Suzuki, R. M. Stephens, N. A. Jenkins, and N. G. Copeland. 2004. RTCGD: retroviral tagged cancer gene database. Nucleic Acids Res. 32:D523–D527.
   PubMed Web of Science ®Google Scholar
• Akimzhanov, A., L. Krenacs, T. Schlegel, S. Klein-Hessling, E. Bagdi, E. Stelkovics, E. Kondo, S. Chuvpilo, P. Wilke, A. Avots, S. Gattenlohner, H. K. Muller-Hermelink, A. Palmetshofer, and E. Serfling. 2008. Epigenetic changes and suppression of the nuclear factor of activated T cell 1 (NFATC1) promoter in human lymphomas with defects in immunoreceptor signaling. Am. J. Pathol. 172:215–224.
   PubMedGoogle Scholar
• Baksh, S., H. R. Widlund, A. A. Frazer-Abel, J. Du, S. Fosmire, D. E. Fisher, J. A. DeCaprio, J. F. Modiano, and S. J. Burakoff. 2002. NFATc2-mediated repression of cyclin-dependent kinase 4 expression. Mol. Cell 10:1071–1081.
   PubMed Web of Science ®Google Scholar
• Bonzheim, I., E. Geissinger, S. Roth, A. Zettl, A. Marx, A. Rosenwald, H. K. Muller-Hermelink, and T. Rudiger. 2004. Anaplastic large cell lymphomas lack the expression of T-cell receptor molecules or molecules of proximal T-cell receptor signaling. Blood 104:3358–3360.
   PubMed Web of Science ®Google Scholar
• Buchholz, M., A. Schatz, M. Wagner, P. Michl, T. Linhart, G. Adler, T. M. Gress, and V. Ellenrieder. 2006. Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+/calcineurin signaling pathway. EMBO J. 25:3714–3724.
   PubMed Web of Science ®Google Scholar
• Caetano, M. S., A. Vieira-de-Abreu, L. K. Teixeira, M. B. Werneck, M. A. Barcinski, and J. P. Viola. 2002. NFATC2 transcription factor regulates cell cycle progression during lymphocyte activation: evidence of its involvement in the control of cyclin gene expression. FASEB J. 16:1940–1942.
   PubMed Web of Science ®Google Scholar
• Carvalho, L. D., L. K. Teixeira, N. Carrossini, A. T. Caldeira, K. M. Ansel, A. Rao, and J. P. Viola. 2007. The NFAT1 transcription factor is a repressor of cyclin A2 gene expression. Cell Cycle 6:1789–1795.
   PubMed Web of Science ®Google Scholar
• Chang, D. W., G. F. Claassen, S. R. Hann, and M. D. Cole. 2000. The c-Myc transactivation domain is a direct modulator of apoptotic versus proliferative signals. Mol. Cell. Biol. 20:4309–4319.
   PubMed Web of Science ®Google Scholar
• Chuvpilo, S., A. Avots, F. Berberich-Siebelt, J. Glockner, C. Fischer, A. Kerstan, C. Escher, I. Inashkina, F. Hlubek, E. Jankevics, T. Brabletz, and E. Serfling. 1999. Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes. J. Immunol. 162:7294–7301.
   PubMed Web of Science ®Google Scholar
• Chuvpilo, S., M. Zimmer, A. Kerstan, J. Glockner, A. Avots, C. Escher, C. Fischer, I. Inashkina, E. Jankevics, F. Berberich-Siebelt, E. Schmitt, and E. Serfling. 1999. Alternative polyadenylation events contribute to the induction of NF-ATc in effector T cells. Immunity 10:261–269.
   PubMed Web of Science ®Google Scholar
• Chuvpilo, S., E. Jankevics, D. Tyrsin, A. Akimzhanov, D. Moroz, M. K. Jha, J. Schulze-Luehrmann, B. Santner-Nanan, E. Feoktistova, T. Konig, A. Avots, E. Schmitt, F. Berberich-Siebelt, A. Schimpl, and E. Serfling. 2002. Autoregulation of NFATc1/A expression facilitates effector T cells to escape from rapid apoptosis. Immunity 16:881–895.
   PubMed Web of Science ®Google Scholar
• Clipstone, N. A., and G. R. Crabtree. 1992. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 357:695–697.
   PubMed Web of Science ®Google Scholar
• de la Pompa, J. L., L. A. Timmerman, H. Takimoto, H. Yoshida, A. J. Elia, E. Samper, J. Potter, A. Wakeham, L. Marengere, B. L. Langille, G. R. Crabtree, and T. W. Mak. 1998. Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum. Nature 392:182–186.
   PubMed Web of Science ®Google Scholar
• Duque, J., M. Fresno, and M. A. Iniguez. 2005. Expression and function of the nuclear factor of activated T cells in colon carcinoma cells: involvement in the regulation of cyclooxygenase-2. J. Biol. Chem. 280:8686–8693.
   PubMedGoogle Scholar
• Fu, L., Y. C. Lin-Lee, L. V. Pham, A. Tamayo, L. Yoshimura, and R. J. Ford. 2006. Constitutive NF-κB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B-cell lymphomas. Blood 107:4540–4548.
   PubMed Web of Science ®Google Scholar
• Glud, S. Z., A. B. Sorensen, M. Andrulis, B. Wang, E. Kondo, R. Jessen, L. Krenacs, E. Stelkovics, M. Wabl, E. Serfling, A. Palmetshofer, and F. S. Pedersen. 2005. A tumor-suppressor function for NFATc3 in T-cell lymphomagenesis by murine leukemia virus. Blood 106:3546–3552.
   PubMedGoogle Scholar
• Hanahan, D., and R. A. Weinberg. 2000. The hallmarks of cancer. Cell 100:57–70.
   PubMed Web of Science ®Google Scholar
• Heit, J. J., A. A. Apelqvist, X. Gu, M. M. Winslow, J. R. Neilson, G. R. Crabtree, and S. K. Kim. 2006. Calcineurin/NFAT signalling regulates pancreatic beta-cell growth and function. Nature 443:345–349.
   PubMed Web of Science ®Google Scholar
• Hodge, M. R., A. M. Ranger, F. Charles de la Brousse, T. Hoey, M. J. Grusby, and L. H. Glimcher. 1996. Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice. Immunity 4:397–405.
   PubMed Web of Science ®Google Scholar
• Iniguez, M. A., S. Martinez-Martinez, C. Punzon, J. M. Redondo, and M. Fresno. 2000. An essential role of the nuclear factor of activated T cells in the regulation of the expression of the cyclooxygenase-2 gene in human T lymphocytes. J. Biol. Chem. 275:23627–23635.
   PubMed Web of Science ®Google Scholar
• Latinis, K. M., L. A. Norian, S. L. Eliason, and G. A. Koretzky. 1997. Two NFAT transcription factor binding sites participate in the regulation of CD95 (Fas) ligand expression in activated human T cells. J. Biol. Chem. 272:31427–31434.
   PubMedGoogle Scholar
• Liu, Y., G. L. Borchert, A. Surazynski, C. A. Hu, and J. M. Phang. 2006. Proline oxidase activates both intrinsic and extrinsic pathways for apoptosis: the role of ROS/superoxides, NFAT and MEK/ERK signaling. Oncogene 25:5640–5647.
   PubMed Web of Science ®Google Scholar
• Lowe, S. W., E. Cepero, and G. Evan. 2004. Intrinsic tumour suppression. Nature 432:307–315.
   PubMed Web of Science ®Google Scholar
• Luo, C., E. Burgeon, and A. Rao. 1996. Mechanisms of transactivation by nuclear factor of activated T cells-1. J. Exp. Med. 184:141–147.
   PubMed Web of Science ®Google Scholar
• Macian, F. 2005. NFAT proteins: key regulators of T-cell development and function. Nat. Rev. Immunol. 5:472–484.
   PubMed Web of Science ®Google Scholar
• Marafioti, T., M. Pozzobon, M. L. Hansmann, R. Ventura, S. A. Pileri, H. Roberton, S. Gesk, P. Gaulard, T. F. Barth, M. Q. Du, L. Leoncini, P. Moller, Y. Natkunam, R. Siebert, and D. Y. Mason. 2005. The NFATc1 transcription factor is widely expressed in white cells and translocates from the cytoplasm to the nucleus in a subset of human lymphomas. Br J. Haematol. 128:333–342.
   PubMed Web of Science ®Google Scholar
• Marshall, C. J. 1991. Tumor suppressor genes. Cell 64:313–326.
   PubMed Web of Science ®Google Scholar
• Medyouf, H., H. Alcalde, C. Berthier, M. C. Guillemin, N. R. dos Santos, A. Janin, D. Decaudin, H. de The, and J. Ghysdael. 2007. Targeting calcineurin activation as a therapeutic strategy for T-cell acute lymphoblastic leukemia. Nat. Med. 13:736–741.
   PubMed Web of Science ®Google Scholar
• Monticelli, S., and A. Rao. 2002. NFAT1 and NFAT2 are positive regulators of IL-4 gene transcription. Eur. J. Immunol. 32:2971–2978.
   PubMed Web of Science ®Google Scholar
• Neal, J. W., and N. A. Clipstone. 2003. A constitutively active NFATc1 mutant induces a transformed phenotype in 3T3-L1 fibroblasts. J. Biol. Chem. 278:17246–17254.
   PubMed Web of Science ®Google Scholar
• Okamura, H., J. Aramburu, C. Garcia-Rodriguez, J. P. Viola, A. Raghavan, M. Tahiliani, X. Zhang, J. Qin, P. G. Hogan, and A. Rao. 2000. Concerted dephosphorylation of the transcription factor NFAT1 induces a conformational switch that regulates transcriptional activity. Mol. Cell 6:539–550.
   PubMedGoogle Scholar
• Oum, J. H., J. Han, H. Myung, M. Hleb, S. Sharma, and J. Park. 2002. Molecular mechanism of NFAT family proteins for differential regulation of the IL-2 and TNF-alpha promoters. Mol. Cell 13:77–84.
   Google Scholar
• Pham, L. V., A. T. Tamayo, L. C. Yoshimura, Y. C. Lin-Lee, and R. J. Ford. 2005. Constitutive NF-κB and NFAT activation in aggressive B-cell lymphomas synergistically activates the CD154 gene and maintains lymphoma cell survival. Blood 106:3940–3947.
   PubMed Web of Science ®Google Scholar
• Plyte, S., M. Boncristiano, E. Fattori, F. Galvagni, S. R. Paccani, M. B. Majolini, S. Oliviero, G. Ciliberto, J. L. Telford, and C. T. Baldari. 2001. Identification and characterization of a novel nuclear factor of activated T-cells-1 isoform expressed in mouse brain. J. Biol. Chem. 276:14350–14358.
   PubMedGoogle Scholar
• Ranger, A. M., M. J. Grusby, M. R. Hodge, E. M. Gravallese, F. C. de la Brousse, T. Hoey, C. Mickanin, H. S. Baldwin, and L. H. Glimcher. 1998. The transcription factor NF-ATc is essential for cardiac valve formation. Nature 392:186–190.
   PubMed Web of Science ®Google Scholar
• Ranger, A. M., M. Oukka, J. Rengarajan, and L. H. Glimcher. 1998. Inhibitory function of two NFAT family members in lymphoid homeostasis and Th2 development. Immunity 9:627–635.
   PubMedGoogle Scholar
• Ranger, A. M., L. C. Gerstenfeld, J. Wang, T. Kon, H. Bae, E. M. Gravallese, M. J. Glimcher, and L. H. Glimcher. 2000. The nuclear factor of activated T cells (NFAT) transcription factor NFATp (NFATc2) is a repressor of chondrogenesis. J. Exp. Med. 191:9–22.
   PubMed Web of Science ®Google Scholar
• Rao, A., C. Luo, and P. G. Hogan. 1997. Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 15:707–747.
   PubMed Web of Science ®Google Scholar
• Schuh, K., B. Kneitz, J. Heyer, U. Bommhardt, E. Jankevics, F. Berberich-Siebelt, K. Pfeffer, H. K. Muller-Hermelink, A. Schimpl, and E. Serfling. 1998. Retarded thymic involution and massive germinal center formation in NF-ATp-deficient mice. Eur. J. Immunol. 28:2456–2466.
   PubMed Web of Science ®Google Scholar
• Schwering, I., A. Brauninger, U. Klein, B. Jungnickel, M. Tinguely, V. Diehl, M. L. Hansmann, R. Dalla-Favera, K. Rajewsky, and R. Kuppers. 2003. Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 101:1505–1512.
   PubMed Web of Science ®Google Scholar
• Shibasaki, F., E. R. Price, D. Milan, and F. McKeon. 1996. Role of kinases and the phosphatase calcineurin in the nuclear shuttling of transcription factor NF-AT4. Nature 382:370–373.
   PubMed Web of Science ®Google Scholar
• Viola, J. P., L. D. Carvalho, B. P. Fonseca, and L. K. Teixeira. 2005. NFAT transcription factors: from cell cycle to tumor development. Braz. J. Med. Biol. Res. 38:335–344.
   PubMed Web of Science ®Google Scholar
• Wang, Q., Y. Ji, X. Wang, and B. M. Evers. 2000. Isolation and molecular characterization of the 5′-upstream region of the human TRAIL gene. Biochem. Biophys. Res. Commun. 276:466–471.
   PubMedGoogle Scholar
• Xanthoudakis, S., J. P. Viola, K. T. Shaw, C. Luo, J. D. Wallace, P. T. Bozza, D. C. Luk, T. Curran, and A. Rao. 1996. An enhanced immune response in mice lacking the transcription factor NFAT1. Science 272:892–895.
   PubMed Web of Science ®Google Scholar
• Yoshida, H., H. Nishina, H. Takimoto, L. E. Marengere, A. C. Wakeham, D. Bouchard, Y. Y. Kong, T. Ohteki, A. Shahinian, M. Bachmann, P. S. Ohashi, J. M. Penninger, G. R. Crabtree, and T. W. Mak. 1998. The transcription factor NF-ATc1 regulates lymphocyte proliferation and Th2 cytokine production. Immunity 8:115–124.
   PubMed Web of Science ®Google Scholar